Cargando…
Patient-relevant health outcomes for von Willebrand disease, platelet function disorders, and rare bleeding disorders: a Delphi study
BACKGROUND: To assess patient value, it is essential to regularly measure health outcomes that matter to patients. It is currently unknown which health outcomes are important for patients with autosomal inherited bleeding disorders. OBJECTIVES: This study aimed to assess which health outcomes are im...
Autores principales: | van Hoorn, Evelien S., Lingsma, Hester F., Cnossen, Marjon H., Gouw, Samantha C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579528/ https://www.ncbi.nlm.nih.gov/pubmed/37854454 http://dx.doi.org/10.1016/j.rpth.2023.102201 |
Ejemplares similares
-
Patient‐reported outcomes in autosomal inherited bleeding disorders: A systematic literature review
por: van Hoorn, Evelien S., et al.
Publicado: (2022) -
ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020) -
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders
por: Castaman, Giancarlo, et al.
Publicado: (2017) -
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients
por: Swinkels, Maurice, et al.
Publicado: (2022) -
Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding
por: Atiq, Ferdows, et al.
Publicado: (2021)